Angiodynamic Inc (ANGO): Next-Year EPS Estimate 29.73%
As of 2026-04-05, Angiodynamic Inc (ANGO) has a next-year EPS growth estimate of 29.73%.
On 2026-04-03, analyst consensus for ANGO's next-year EPS growth shifted from 62.07% to 29.73% — a negative change of 32.34 percentage points. The revised estimate has been sustained across 2 subsequent trading sessions.
Current Snapshot
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- EPS growth next year
- 29.73%
- EPS growth this year
- N/A
- EPS next quarter (est)
- -$0.09
- Last price
- $10.31
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-04-05 | 29.73% | N/A | -$0.09 | $10.31 |
| 2026-04-03 | 29.73% | N/A | -$0.09 | $10.31 |
| 2026-04-01 | 62.07% | N/A | N/A | $11.94 |
| 2026-04-01 | 62.07% | N/A | N/A | $11.94 |
| 2026-04-01 | 62.07% | N/A | N/A | $11.94 |
| 2026-04-01 | 62.07% | N/A | N/A | $11.94 |
| 2026-03-31 | 62.07% | N/A | N/A | $11.37 |
| 2026-03-31 | 62.07% | N/A | N/A | $11.37 |
| 2026-03-31 | 62.07% | N/A | N/A | $11.37 |
| 2026-03-30 | 62.07% | N/A | N/A | $10.87 |
| 2026-03-30 | 62.07% | N/A | N/A | $10.87 |
| 2026-03-30 | 62.07% | N/A | N/A | $10.87 |
| 2026-03-29 | 62.07% | N/A | N/A | $10.90 |
| 2026-03-29 | 62.07% | N/A | N/A | $10.90 |
| 2026-03-27 | 62.07% | N/A | N/A | $10.90 |
| 2026-03-26 | 62.07% | N/A | N/A | $11.27 |
| 2026-03-26 | 62.07% | N/A | N/A | $11.27 |
| 2026-03-26 | 62.07% | N/A | N/A | $11.27 |
| 2026-03-25 | 62.07% | N/A | N/A | $11.22 |
| 2026-03-25 | 62.07% | N/A | N/A | $11.22 |
| 2026-03-25 | 62.07% | N/A | N/A | $11.22 |
| 2026-03-24 | 62.07% | N/A | N/A | $10.63 |
| 2026-03-24 | 62.07% | N/A | N/A | $10.63 |
| 2026-03-24 | 62.07% | N/A | N/A | $10.63 |
| 2026-03-23 | 62.07% | N/A | N/A | $10.71 |
| 2026-03-20 | 62.07% | N/A | N/A | $10.41 |
| 2026-03-19 | 62.07% | N/A | N/A | $10.63 |
| 2026-03-18 | 62.07% | N/A | N/A | $10.40 |
| 2026-03-17 | 62.07% | N/A | N/A | $10.71 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Angiodynamic Inc's next-year EPS growth estimate?▾
As of 2026-04-05, Angiodynamic Inc (ANGO) has a next-year EPS growth estimate of 29.73%, based on analyst consensus.
When was the latest EPS estimate revision for ANGO?▾
The most recent revision occurred on 2026-04-03, when analysts adjusted the next-year EPS growth estimate from 62.07% to 29.73%.
What sector and industry does Angiodynamic Inc belong to?▾
Angiodynamic Inc operates in the Healthcare sector, specifically the Medical Instruments & Supplies industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. ANGO appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Angiodynamic Inc (ANGO) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports